Open AccessPleurectomy/decortication and hyperthermic intrathoracic chemoperfusion using cisplatin and doxorubicin for malignant pleural mesothelioma
Author(s) -
Laura V. Klotz,
Michael Lindner,
Martin Eichhorn,
U Grützner,
Ina Koch,
Hauke Winter,
Teresa Kauke,
Thomas Duell,
Rudolf Hatz
Publication year - 2019
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2019.04.93
Subject(s) - medicine , decortication , pleurectomy , mesothelioma , extrapleural pneumonectomy , cisplatin , surgery , chemotherapy , peritoneal mesothelioma , oncology , pneumonectomy , pathology , lung cancer
Malignant pleural mesothelioma (MPM) is an aggressive malignancy with few long-term survivors. Despite the dismal prognosis, hyperthermic intrathoracic chemoperfusion (HITHOC) was shown to improve survival in a selective group of patients. We analyzed the influence of HITHOC following pleurectomy and decortication on postoperative morbidity and overall survival for patients suffering from localized mesothelioma.